Stock ACRS ACLARIS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Aclaris Therapeutics, Inc.

Equities

ACRS

US00461U1051

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-17 EDT 		5-day change 1st Jan Change
1.19 USD +0.85% Intraday chart for Aclaris Therapeutics, Inc. +1.71% +13.33%
05-07 Transcript : Aclaris Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024
05-07 Earnings Flash (ACRS) ACLARIS THERAPEUTICS Reports Q1 Revenue $2.4M, vs. Street Est of $2M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ACLARIS THERAPEUTICS, INC. Stock Aclaris Therapeutics, Inc.
 84.81M - -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.12B
LONZA GROUP AG Stock Lonza Group AG
 42.05B
CELLTRION, INC. Stock Celltrion, Inc.
 29.18B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.02B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 18.9B -
  1. Stock Market
  2. Equities
  3. ACRS Stock
  4. Charts Aclaris Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW